EPLERON

EPLERON
Eplerenone 25 mg & 50 mg

Selective Aldosteron Blockade for Cardiovascular Protection A More Selective MRA Option.

Detail :

EPLERON contains Eplerenone , a selective mineralocorticoid receptor antagonist positioned for cardiovascular patients requiring aldosterone blockade, including heart failure and hypertension management

With its more selective MRA profile, EPLERON is designed to support cardiovascular protection while offering lower anti androgenic side effect concern compared with non selective MRA option such as spironolactone

Packaging            : Box @ 30 tablet